Participants
A total of 96 subjects with probable FTD and 84 healthy subjects (HS) were included in the study.
The frontotemporal lobar degeneration neuroimaging initiative (FTLDNI) dataset was used to select subjects’ scans for the “selection cohort” and “test cohort” (Table 1). FTLDNI was founded through the National Institute of Aging and started in 2010. The primary aims of FTLDNI are to identify neuroimaging modalities and methods of analysis for tracking frontotemporal lobar degeneration (FTLD) and to compare the value of neuroimaging with other biomarkers in diagnostic roles. The Principal Investigator of FTLDNI is Dr. Howard Rosen, (University of California, San Francisco). The data is the result of collaborative efforts at three different sites in North America. For more information, please visit: https://memory.ucsf.edu/research/studies/nifd [
-High-Quality-100x70.jpg "Commentary on Breakthrough COVID-19 Infections from Brett Elicker, MD")
